Skip to main content
. 2017 Mar 28;2017(3):CD011343. doi: 10.1002/14651858.CD011343.pub2

EUCTR2012‐004170‐26‐IT.

Trial name or title EUCTR2012‐004170‐26‐IT.
Methods Randomised double‐blinded placebo‐controlled trial.
Participants Patients with primary sclerosing cholangitis.
Interventions N‐acetylcysteine 600 mg vs placebo.
Outcomes Quality of life.
Starting date Not stated.
Contact information agasbarrini@RM.UNICATT.IT
Notes Not recruiting.